Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study on the Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

NCT04950868 is registered in ClinicalTrials.gov with Verinder Sharma as lead sponsor.

NCT NCT04950868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study on the Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
Lead sponsor
Verinder Sharma
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 18, 2022
Completion date
June 1, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression